Loading
Life sciences · Journal article
Gastroenterology Insights · September 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common chronic liver disease in children and adolescents, paralleling the global increase in pediatric obesity. Despite its growing clinical impact, the diagnosis and staging of pediatric MASLD/MASH remain challenging due to the limitations of current non-invasive tools and the complexity of histopathological evaluation. Liver biopsy remains the reference standard for assessing disease activity and fibrosis stage; however, its invasive nature and the substantial inter-observer variability among pathologists highlight the need for more objective and reproducible approaches. In this review, we summarize the current challenges in the diagnosis and management of pediatric MASLD/MASH and discuss the emerging role of artificial intelligence (AI)-driven models in this field. We explore the application of machine learning and deep learning approaches for non-invasive assessment of hepatic steatosis, as well as their potential to improve digital pathology-based evaluation of steatosis, hepatocellular ballooning, inflammation, and fibrosis. Furthermore, we discuss the opportunities and limitations associated with AI implementation in clinical practice, including algorithmic bias, interpretability, data quality, and the need for external validation.